BRPI0516770A - vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente - Google Patents

vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente

Info

Publication number
BRPI0516770A
BRPI0516770A BRPI0516770-1A BRPI0516770A BRPI0516770A BR PI0516770 A BRPI0516770 A BR PI0516770A BR PI0516770 A BRPI0516770 A BR PI0516770A BR PI0516770 A BRPI0516770 A BR PI0516770A
Authority
BR
Brazil
Prior art keywords
polysaccharide
protein
vaccine
conjugates
protein conjugates
Prior art date
Application number
BRPI0516770-1A
Other languages
English (en)
Inventor
Robert P Ryall
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Publication of BRPI0516770A publication Critical patent/BRPI0516770A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)

Abstract

VACINA E CONJUGADOS DE PROTEìNA - DERIVADOS DE POLISSACARìDEO DE MENINGOCóCICO MULTIVALENTE. A presente invenção descreve conjugados de derivados de polissacarídeo-proteína, uma composição compreendendo um ou mais de tais conjugados de derivado de polissacarídeo-proteína e métodos para imunização de pacientes humanos com os mesmos. Os conjugados de derivado polissacarídeo-proteína são polissacarídeos capsulares purificados de soro-grupo A, C, W-135, e Y de Neisseria meningitidis, derivado clinicamente ativado e seletivamente ligado a uma proteína portadora através de uma ligação química covalente, formando conjugado de polissacarídeo-proteína capazes de eliciar imunidade duradoura a uma variedade de cepas de N. meningitidis
BRPI0516770-1A 2004-09-21 2005-09-21 vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente BRPI0516770A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61212304P 2004-09-21 2004-09-21
PCT/US2005/033761 WO2006034320A2 (en) 2004-09-21 2005-09-21 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine

Publications (1)

Publication Number Publication Date
BRPI0516770A true BRPI0516770A (pt) 2008-09-23

Family

ID=36090637

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0516770-1A BRPI0516770A (pt) 2004-09-21 2005-09-21 vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente

Country Status (10)

Country Link
EP (2) EP1791562A4 (pt)
JP (2) JP2008513541A (pt)
KR (1) KR20070095868A (pt)
CN (1) CN101072586A (pt)
AU (1) AU2005286798A1 (pt)
BR (1) BRPI0516770A (pt)
CA (1) CA2580693A1 (pt)
IL (1) IL181951A0 (pt)
MX (1) MX2007003292A (pt)
WO (1) WO2006034320A2 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070101207A (ko) * 2004-08-30 2007-10-16 사노피 파스퇴르 인크 다가 수막구균 유도체화된 다당류-단백질 접합체 및 백신
GB2468803B (en) * 2005-05-19 2011-01-19 Exocyte Ltd Screening methods for bacterial killing
WO2011011879A1 (en) * 2009-07-31 2011-02-03 National Research Council Of Canada H. pylori lipopolysaccharide outer core epitope
EP2612148B1 (en) * 2010-09-04 2019-06-12 GlaxoSmithKline Biologicals SA Bactericidal antibody assays to assess immunogenicity and potency of meningococcal capsular saccharide vaccines
CN102462839B (zh) * 2010-11-12 2016-03-30 北京生物制品研究所 多糖结合疫苗及其制备方法
US10598666B2 (en) 2012-03-08 2020-03-24 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines
BR112015004817A2 (pt) * 2012-09-10 2017-07-04 Glycovaxyn Ag bioconjugados compreendendo antígenos modificados e seus usos
CN106046127A (zh) * 2016-08-10 2016-10-26 成都生物制品研究所有限责任公司 一种白喉类毒素的制备方法
BR112019003992A2 (pt) 2016-09-02 2019-05-28 Sanofi Pasteur Inc vacina contra neisseria meningitidis
CN106397537B (zh) * 2016-10-13 2020-01-07 李红臣 一种高效快速的多糖蛋白结合疫苗纯化分析方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4619828A (en) 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
US5153312A (en) 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5422427A (en) 1991-09-17 1995-06-06 The United States Of America As Represented By The United States Department Of Health And Human Services Pneumococcal fimbrial protein A
US5445817A (en) 1992-08-21 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
US5965714A (en) * 1997-10-02 1999-10-12 Connaught Laboratories, Inc. Method for the covalent attachment of polysaccharides to protein molecules
US6146902A (en) * 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
GB0022742D0 (en) * 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
SI21352A (sl) * 2001-01-23 2004-06-30 Aventis Pasteur Multivalentno meningokokno cepivo iz konjugata polisaharida-proteina
WO2002091998A2 (en) * 2001-05-11 2002-11-21 Aventis Pasteur, Inc. Novel meningitis conjugate vaccine
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
ES2616180T3 (es) * 2002-03-26 2017-06-09 Glaxosmithkline Biologicals Sa Sacáridos modificados con estabilidad mejorada en agua para su uso como medicamento
CN1852733A (zh) * 2003-05-07 2006-10-25 安万特巴斯德公司 多价脑膜炎球菌衍生的多糖－蛋白质缀合物及疫苗
KR20070101207A (ko) * 2004-08-30 2007-10-16 사노피 파스퇴르 인크 다가 수막구균 유도체화된 다당류-단백질 접합체 및 백신

Also Published As

Publication number Publication date
MX2007003292A (es) 2007-09-07
JP2012140457A (ja) 2012-07-26
WO2006034320A2 (en) 2006-03-30
EP2345422A1 (en) 2011-07-20
WO2006034320A3 (en) 2006-09-28
CA2580693A1 (en) 2006-03-30
EP1791562A4 (en) 2008-07-09
KR20070095868A (ko) 2007-10-01
JP2008513541A (ja) 2008-05-01
EP1791562A2 (en) 2007-06-06
IL181951A0 (en) 2007-07-04
CN101072586A (zh) 2007-11-14
AU2005286798A1 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
BRPI0410341B8 (pt) conjugados de polissacarídeo-proteína derivatizados de meningococos multivalentes e vacina
BR0206672A (pt) Vacina conjugada de proteìna de polissacarìdeo meningocócico multivalente
BRPI0411875A (pt) método de imunização contra os sorogrupos a e c de neisseria meningitidis
BRPI0612670B1 (pt) composição imunogênica, vacina a compreendendo e kit de vacina para a administração concomitante ou sequencial
CR10123A (es) Vacuna.
BRPI0407101A (pt) Vacinas meningocócicas mucosais
CL2016000566A1 (es) Método para para preparar una composición inmunogénica multivalente que comprende 13 conjugados de un serotipo diferente de streptococcus pneumoniae, donde cada uno de los conjugados contiene un polisacárido capsular diferente conjugado a la proteína portadora crm197. div. sol. madre n° 200600802 e hija cl 201702206.
EA200801839A1 (ru) Иммуногенная композиция
BR112012019757B8 (pt) Composição imunogênica, e, uso de uma mistura de conjugado de polissacarídeo-proteína multivalente
CY1116264T1 (el) Αντισωματα κατα ανθρωπινης αγγειοποιητινης 2
UA99659C2 (uk) Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
ATE496623T1 (de) Oxcarbazepin-zubereitungen für kontrollierte freisetzung mit sigmoidalem freisetzungsprofil
PE20080748A1 (es) Vacuna a base de los de cepas de neisseria
MX2014009250A (es) Composicion inmunogenica.
BRPI0516770A (pt) vacina e conjugados de proteìna - derivados de polissacarìdeo de meningocócico multivalente
WO2006002402A3 (en) Polysaccharide derivatives and uses in induction of an immune response
BRPI0515125A (pt) conjugados de polissacarìdeo derivatizado-proteìna multivalentes, meningocócicos e vacina
BRPI0516372A (pt) conjugados de polissacarìdeo-proteìna derivatizados meningocócicos multivalentes e vacina
BRPI0411815A (pt) vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas
BR112015024014A2 (pt) vacina conjugada
RU2008131066A (ru) Фармацевтическая композиция, содержащая белок nma0939

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2150 DE 20/03/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2272 DE 22/07/2014.